Table 1.
Control Group (n = 25) | RxDx Group (n = 28) | p | |
---|---|---|---|
Male | 84% | 82% | NS |
CABG | 16 | 16 | NS |
Aortic valve replacement | 4 | 6 | NS |
Mitral valve replacement | 2 | 4 | NS |
CABG + aortic valve replacement | 2 | 1 | NS |
CABG + mitral valve replacement | 1 | 1 | NS |
Age (years) | 68 (51–88) | 65 (52–86) | .32 |
Weight (kg) | 81 (102–54) | 73 (41–122) | .39 |
Body surface area (m2) | 1.9 (1.5–2.2) | 1.8 (1.4–2.4) | .32 |
Cross-clamp time (minutes) | 55 (29–106) | 62 (28–167) | .42 |
Cardiopulmonary bypass (minutes) | 82 (45–151) | 92 (52–218) | .61 |
Baseline ACT (seconds) | 137 (117–206) | 136 (91–165) | .20 |
Baseline hematocrit (%) | 39 (25–46) | 38 (21–45) | .43 |
EuroSCORE | 4 (2–9) | 4 (1–10) | .73 |
Values are presented as median and range. NS, not significant; CABG, coronary artery bypass grafting; ACT, activated clotting time.